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The New Challenges for Medical 
Ethics
Liliana Lorettu, Jocelyn Aubut and Rosagemma Ciliberti
Abstract
The evolution of medicine confronts healthcare professionals with new  ethical 
challenges. Elements such as professional secrecy, patient benefit, justice in the 
distribution of resources are put in crisis by the evolution of medical procedures. 
Today, doctors must make life-and-death decisions about many patients. As 
the resources are not enough for all patients, the ‘first-come, first-served’ cri-
terion crumbles under the weight of the overwhelming demand for treatment. 
Consequently, they can no longer make treatment decisions based only on pro-
portionality and clinical appropriateness criteria. They must take into account the 
availability of resources and prioritise patients with ‘the longer life expectancy’. 
This amounts to saying ‘the weakest will die’ ... with the doctors’ consent. While the 
guidelines issued by scientific societies may well protect doctors from lawsuits, the 
choice of who to treat and who to let die is left to the conscience of the individual 
doctor; and it is a choice sharply clashing with the Hippocratic oath and with 
professional and personal ethics. This and others are a real ethical problem.
Keywords: medical ethics, professional responsibility, availability of resources
1. Introduction
Biomedical ethics has made giant strides over the past decades and has come 
to be recognised as integral to medical education. This has encouraged the grow-
ing inclusion of the teaching of medical ethics, together with that of the human 
sciences, in the syllabi of medical and nursing schools. In the 1980s, increased 
awareness of ethical issues shone a light on some excesses of medical research and 
medical paternalism which conflicted with ethical principles. The 1990s saw the 
establishment of the first medical ethics committees in hospitals, overseeing both 
research and clinical practice. Since the 2000s, the various bodies regulating the 
doctors’ right to practice have issued regulations, guidelines and recommendations 
laying down formal ethical rules for medical practice, together with a system of 
penalties for infringement of these rules.
Many social and cultural factors have contributed to the increase in ethical 
concerns. The increase in individual civil liberties, codified in various Charters of 
Citizens’ Rights, has fuelled a growing drive to claim new rights in previously unex-
plored areas. The development of biomedical technologies has created new fron-
tiers, such as the attempt to shape one’s own medical fate, as in the case of the actress 
Angelina Jolie, who chose to undergo preventive double mastectomy and subsequent 
ovariectomy because she carried a gene that greatly increased (over 80%) her risk 
of developing an aggressive and often fatal type of breast cancer, or the decision of a 
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British manager to have his prostate removed for the same reason. In the meantime, 
the constant budget cuts have increased the need to make very complex choices.
Recently, the Covid-19 pandemic has confronted us with specific ethical dilem-
mas, in particular the choice about who to treat or not to treat in a health emergency 
with scarce resources.
The growing ethical concerns have highlighted the fact that doctors only receive 
very basic training in medical ethics during their studies and practical training. 
Some studies even show that the awareness of ethical issues of students and trainees 
decreases as they advance in their studies [1, 2].
Most doctors trust their ethical judgement and believe that their decisions are 
morally sound. Yet most doctors lack adequate training and theoretical knowledge 
of ethical issues to support their beliefs and choices in a manner that stands up to 
scrutiny. The ethical judgement of most doctors is based on their professional life 
experience, personal opinions, beliefs and values, but few know the theoretical 
foundations of biomedical ethics and moral decision-making.
The first part of this paper outlines the key theoretical concepts framing ethical 
decision-making by physicians. Next, the principles governing the ethical decision-
making process are presented. This is important because ethics is not only about 
the medical decision, but also about the process for reaching that decision. Certain 
issues in the application of ethical principles and the challenges brought by current 
events to medical ethics are also discussed.
2.  Historical overview and remarks on the relationship between medical 
ethics and bioethics
The birth of bioethics as understood today is closely linked to the giant strides 
made by the biomedical sciences and technologies (most notably molecular biology 
and genetic engineering) around the 1970s.
The gradual unlocking of the mechanisms of life, coupled with the possibility 
of manipulating and modifying living beings, enabled a number of procedures that 
gave rise to widespread ethical concerns: medically assisted reproduction, tissue 
and organ transplantation, genetic intervention, the possibility of artificial life 
independent of ‘natural’ life, euthanasia, cloning, etc.
The word Bio-Ethik was coined by German Protestant pastor and ethicist Fritz 
Jahr, who used the term to propose a new bioethical imperative that extended to all 
living beings Kant’s categorical imperative of respect for all persons [3, 4].
However, the current meaning of bioethics can be ascribed to American 
oncologist Van Rensselaer Potter, who used this term in a paper entitled Bioethics: 
the science of survival [5] and later in his best-known work Bioethics: a bridge to the 
future [6].
According to Potter, building an ethic based on scientific knowledge is neces-
sary to ensure the very survival of Homo sapiens, which could be threatened if 
research were allowed to proceed unchecked and unfettered. Potter rejected merely 
speculative knowledge and stressed the need to connect ethical values, tradition-
ally confined to the realm of the humanities, with biological facts and thus build a 
‘bridge to the future’.
Potter himself defined bioethics as the ‘knowledge of how to use knowledge’, 
to highlight the distinctive nature of this discipline as a dialogical meeting point 
between the natural sciences, the social sciences and philosophy.
In his subsequent book, entitled Global Bioethics, Potter made the by now well-
established subdivision of bioethics into three branches: medical ethics, environ-
mental ethics and animal ethics [7].
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It is interesting to note that originally, the scope of bioethics was not restricted 
to medical practice, even though in subsequent years this came to be considered its 
main, if not exclusive, area of concern. Indeed, differently from Potter’s definition 
of bioethics (later followed by Jonas in his work The Responsibility Principle  [8]) the 
term has mostly been applied in the narrower sense given to it by Dutch obstetrician 
Andre E. Hellegers, co-founder of the Kennedy Institute, who considered bioeth-
ics as ethics applied to the biomedical sciences [9]. This narrowing of the scope of 
bioethics from its original reflection on the ethical problems relating to life, ‘bios’ 
in all its complexity, is partly due to the fact that the two centres where bioethics 
research and teaching were first developed (the Kennedy Institute in Washington 
and the Hastings Center in New York) focused on medical issues, specifically, on 
medically assisted reproduction. This meant that issues such as the treatment of 
animals or environmental risks were not considered to fall within the scope of 
bioethics proper.
The close links between the different facets of bioethics and the high complex-
ity of the problems addressed require constant cross-disciplinary dialogue among 
scientists and scholars from a range of disciplines such as philosophy, law, econom-
ics, sociology, ethology, psychology and anthropology [10].
The interdisciplinary nature of bioethics is also in evidence in the current defini-
tion of this discipline, contained in the 2nd edition of the Encyclopedia of bioeth-
ics: ‘Bioethics is the systematic study of the moral dimensions - including moral vision, 
decisions, conduct, and policies - of the life sciences and health care, employing a variety 
of ethical methodologies in an interdisciplinary setting’ [11].
The relationship between ethics and science is certainly at the heart of philo-
sophical reflection and may be summed up in one question: should we do every-
thing we can do?
In the United States, the debate on ethical issues had already started long before 
the breakthroughs in genetics: it was prompted by news of gross abuses committed 
in several clinical trials, namely at the Jewish Chronic Disease Hospital in Brooklyn, 
the Willowbrook State Hospital in New York and in the famous ‘Tuskegee Study 
of Untreated Syphilis in the Negro Male’ which began in 1932 and continued until 
1972 [12].
However, the historical roots of bioethics and, in particular, of medical ethics, 
can be traced further back in time by a deeper examination of the relationship 
between science and ethics.
The atrocities committed in the experiments on concentration camp prisoners 
in Nazi Germany dramatically revealed, well before the later events that prompted 
the appearance of the term ‘bioethics’ in the literature, the need to investigate the 
relationship between ethics and science.
The Nuremberg Code was the first document to enshrine in specific rules the 
ethical principles that govern research on human subject. The Code, which although 
it never attained legal value has a universal moral value, established for the first 
time the following standards for human experiments:
• The voluntary consent of the human subject is absolutely essential: this means 
that the person involved must be given detailed prior information about the 
nature, purpose, duration, means and risks of the experiment;
• the experiment must be justified in terms of necessity, anticipated results and 
avoidance of injury;
• the risks of the experiment must be carefully weighed against the expected 
benefits;
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• the personnel conducting the experiment must be appropriately trained and 
qualified;
• appropriate equipment and facilities must be used;
• it must be possible to bring the experiment to an end at any time on the initia-
tive of either the human subject or the scientist.
Thus, the Nuremberg Code is a landmark document in the development of 
medical ethics, paving the way for a gradual and profound revision of the doctor-
patient relationship in order to shed the traditional paternalistic approach in favour 
of the principles of consent, shared decision-making and therapeutic alliance.
Following the Nuremberg trial and the consequent drafting of the Nuremberg 
Code (1946), several international instruments on human rights were drafted, 
starting from the Universal Declaration of Human Rights (1948), which laid down 
the first legal principles of bioethics. The Declaration contains strong statements 
on the right to life and physical integrity, together with other fundamental civil and 
political freedoms. In so doing, it opened up a new legal and regulatory path for 
bioethics and inspired and influenced the subsequent development of international 
legislation.
The global and regional documents, charters, declarations and conventions that 
followed explicitly refer to the Universal Declaration of Human Rights as the foun-
dation of their statutes and precepts, including the WMA Declaration of Geneva 
and the International Code of Medical Ethics of 1948 and the WMA Declaration of 
Helsinki on Ethical Principles for Medical Research Involving Human Subjects of 
1964 (with its several subsequent amendments.
However, with regard to the aims of bioethics, it would be reductive and histori-
cally incorrect to limit its statutory, founding aims to the need to fix the ethical 
boundaries for the technical progress of science. As Mori [13] pointed out, what 
the Nuremberg trial itself so dramatically exposed is the need to set limits not to 
the technological advances of science but to the abuse of those advances. Thus, 
Mori reminds us that the core problem of bioethics is not to trace the boundaries 
of technological advancement, pitting science against ethics, but to identify the 
reasons that justify a specific moral judgement. Thus, as remarked by Schiavone 
[14], a crucial premise for any ethical approach to be legitimate and justified is 
that any critical reflection on scientific areas and disciplines should originate and 
develop within science itself and the scientific and technical advances achieved by 
it, instead of referring to a source of regulation outside science.
Far from being a system distinct from science and which attempts to stem its 
progress, bioethics aims to pursue critical and coherent reflection on human dig-
nity, as an instrument of moral control (in the secular sense) over science in terms 
of its impact on human beings and the environment.
The subject matter of bioethics (which concerns itself with the sphere of ‘bios’, 
i.e. living beings) is associated with the theme of the destiny of human beings, 
and thus is an emotionally charged topic, inevitably subject to strong pressures. 
Bioethics is constantly at risk of sliding from the role of neutral and unbiased obser-
vatory – to the extent that such a role can effectively be achieved and maintained – 
onto the dangerous terrain of ideology and its associated dogmatic views.
Returning to the question of the origins of bioethics, it should be noted 
that ethical reflection in medicine dates back to long before Potter’s text. The 
Hippocratic oath is significant evidence of this. The oath, which evidently reflects 
the philosophy and culture of a time when the medical profession had a hieratic 
character, contains the seed bioethics in its principles of non nocere (i.e. ‘do no harm’ 
to the patient) and ‘beneficence’ as cornerstones of the doctor’s activity.
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The Western world has adopted this approach and has formulated codes of 
medical ethics and laws inspired by ethical principles to regulate the exercise of the 
medical profession. These sets of rules are regularly updated in response to cultural 
and ethical developments and to the growing demand for professional standards 
to safeguard not only the interests of medical professionals, but also, and most 
importantly, those of their patients.
In this regard, medical ethics and standards of professional conduct play a major 
role in the physician-patient relationship. This is the setting where protecting the 
patient’s fundamental rights is crucial and where the risk that medical practice may 
infringe the individual’s rights protected by the Constitution is highest. Indeed, 
Figure 1. 
Main documents on medical ethics.
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since ancient times, the power imbalance inherent in the patient-provider relation-
ship has required a framework of principles and rules specifying the physician’s 
duties, in order to protect the patient (Figure 1).
3. General principles
Ethical theories can be grouped for simplicity into two main currents.
One is teleological ethics. Teleological theories focus on the purpose of the deci-
sions taken and on their positive and negative impacts, and assess the consequences 
of the action [15]. These theories are deductive and pragmatic. Among the best 
known are John Stuart Mill’s utilitarianism [16] and American principlism [17]. The 
latter is undoubtedly one of the most widespread currents in medical ethics, at least 
in the United States, and will be discussed below. These theories focus on doing 
good for each individual, but also for the community.
The second current is deontological ethics; this differs fundamentally from 
the teleological approach in that its focus is not on achieving a good outcome but on 
doing what is morally right. The deontological approach is based on a series of ‘prima 
facie’ principles; it is an inductive principle focused on processes rather than on the 
final decision and it refers to the theories of Kant and Habermas [18]. Deontological 
ethics recognises absolute prohibitions, which admit no exceptions for any reason, 
override other duties, are fixed ‘a priori’ and are unchangeable. However, since con-
flict may arise between different duties, priorities must be identified in the hierarchy. 
Thus, a shift occurs from a hierarchy with absolute ‘a priori’ duties to an ethics with 
‘prima facie’ duties, which also requires examination of the circumstances.
Teleological ethics and deontological ethics are two alternative ethical theories 
that determine the moral good or evil of an action.
The key difference between the two theories is that teleological ethics weighs the 
good or evil of an action according to its consequences. By contrast, deontological 
ethics determines the good or evil of an action on the basis of an examination of the 
action itself. Its vision is based on rules that determine the action.
Application of these two theories to end-of-life care can help to clarify the 
difference between them. Under the teleological framework, doctors who practice 
assisted dying focus on the purpose of decisions. They respect the patient’s choice 
to end her suffering when there is no hope of improvement. By contrast, under 
the deontological approach, doctors may refuse to provide assisted dying care on 
the basis of the a priori principle that doctors are trained to treat and not to take 
life. These are two diametrically opposed positions, which require different ethical 
frameworks.
General principles that state universal values of common morality also contrib-
ute to the basic reasoning on medical ethics . Beauchamp and Childress [17] have 
identified a model consisting of four moral principles that constitute the most 
common framework for achieving what is ‘good’ and what is ‘right’ in healthcare. 
‘Principlism’ is a basic framework because it identifies four fundamental principles 
that come into play in most medical decisions, across the different medical speciali-
ties, countries and continents. These principles do not constitute a moral system or 
theory, but offer a framework for reflection on the moral problems encountered, 
and provide a starting point for making a moral judgement and assessing the 
procedure to be followed. The main principles are:
• respect for autonomy/the individual
• beneficence
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The principle of autonomy refers to liberal thought, which has always empha-
sised individual rights and freedom of choice as an expression of the individual’s 
free will. The patient is recognised as possessing critical thinking and decision-
making skills that must be respected. The model that emphasises the autonomy 
principle aims to oppose and overcome the paternalistic approach that has long 
dominated the doctor-patient relationship. The paternalistic model was based on 
an asymmetric relationship between the doctor (acting as a good parent) and the 
patient, who was treated as a ‘child’, unable to make decisions because of his lack 
of scientific and, especially, medical knowledge. This model has been discarded 
by reversing the patient’s role, from a passive one, to that of an autonomous 
person, capable of self-determination according to the principle of individual 
autonomy. The principle of autonomy ensures that the patient is involved in the 
medical decision-making process and protects his right to choose, accept, refuse 
or stop treatment. This is an absolute right of the individual, even where the 
refusal or interruption of treatment might cause adverse health consequences 
or even death. Autonomy implies respect for an individual’s physical and mental 
integrity. A person cannot be forced to receive treatment against her will. The 
patient cannot be subjected to any physical or mental coercion. The principle of 
autonomy also underpins the patient’s right to accurate and exhaustive informa-
tion on the proposed treatment. Recognition of this right has led to development 
of the informed consent procedure. However, for certain specifically identified 
medical conditions that pose a public health threat, the government has the 
coercive power to impose treatment; this can occur, for instance, in the case of 
acute psychiatric patients or highly infectious diseases. However, even in these 
cases, the dignity of the person must always be respected. To apply these rules, 
doctors must know the legislation in force in the country in which they work; in 
any case, they must take all proper actions to minimise the need for coercion and 
maximise the patient’s consent.
The principle of beneficence states that the patient’s well-being is the ultimate 
goal of care. This principle lies at the heart of medicine, whose mission is precisely 
to prevent, diagnose and treat illness in order to promote the patient’s health. It is a 
question of proposing a treatment that is proportionate to the patient’s needs and 
whose benefits for the patient outweigh its possible harms. This principle means 
that doctors may act in the patient’s best interest also by refraining from acting and/
or by acting prudently, always from the viewpoint of the benefit for the patient. 
Traditionally, this principle has been focused on ‘objective’ good, i.e. the outcome 
considered to be good by the doctor. However, cultural and ethical developments 
have gradually led to add to this principle that of autonomy, supporting a more 
subjective interpretation of the patient’s ‘best interest’.
The principle of non-maleficence has been well known to doctors since the time 
of the Hippocratic precept of primum non nocere. Non-maleficence encompasses 
two key concepts. The first is that of not causing harm to patients, even before doing 
them good. The second is the need to properly assess the risks and the benefit/risk 
balance of a treatment, and hence to refrain from prescribing a treatment that, 
although effective, could be harmful to the patient.
The non-maleficence principle is reflected in a number of legal provisions 
regarding wilful medical malpractice, where the patient was intentionally injured, 
or negligent malpractice, where the harm was caused by negligence, inexperience, 
recklessness or failure to comply with laws, regulations, orders or standards.
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The principle of justice requires that all people be treated fairly. It is difficult 
to provide a single definition of justice, as various theories have produced dif-
ferent versions. Egalitarian theories stress the importance of universal access to 
basic necessities [19]. Libertarian theories affirm the right to social and economic 
freedom [19]. Utilitarian doctrines require the balancing of the two principles in 
order to maximise public and private utility [17]. Moreover, the principle of justice 
includes the concept of distributive justice, which states that resources should 
be allocated so as to ensure that access to care is not affected by socio-economic, 
ethnic or other factors which could favour certain sectors of the population to the 
detriment of others. The problem of resource allocation arises at different levels. 
For example, a national government decides which share of funding to allocate to 
finance social and healthcare relative to other sectors such as education, labour, 
transport. Moreover, the healthcare budget is in turn distributed differently 
among the different specialties. Thus, in practice, implementing the distributive 
principle raises complex issues; for instance, to what extent can expensive experi-
mental treatments be justified in patients who have not responded to conventional 
approaches? Some of these treatments can cost more than €100,000 per year and 
clearly erode the sums available to treat other patients.
These four principles are not independent of each other. Rather, they interact in 
all medical situations of varying complexity, engaging in a dialectical relationship 
which requires their careful balancing. The clinician’s art is to fully understand how 
to best weigh these factors on a case-by-case basis, to reach the most appropriate 
decision for the individual patient.
4. The decision-making process
In modern biomedical ethics, the process by which a decision is reached is as 
important as the decision itself. This is why it is necessary to have a clear approach 
that takes into account the problems to be addressed and all the persons concerned.
Figure 2 shows a decision making process according to Jonsen’s four box model 
for decision making which evaluates four fundamental variables: medical indica-
tions, patient and family preferences, quality of life and contextual features [20].
The approach proposed here is one example, among the many available, of a 
framework to guide the decision-making process. The approach is based on a series 
of questions, which are set out and explained below.
1. What are the facts, the circumstances? This question prompts a description of 
the clinical problem, concurring factors and psychosocial and environmen-
tal aspects. The starting point is awareness that the interaction is not with an 
illness, but with a sick person with a life history, family, affections, job and 
deep personal, existential and ideological values. Each participant will, in their 
own way, experience the impact of the decision. Clearly, at the centre of the 
decision is the patient, being the person that will ultimately make the decision 
and bear the consequences. The available options should be assessed from a 
clinical standpoint, considering the likelihood of success of the option chosen. 
For example, what are the chances that a patient with aggressive cancer will 
survive mutilating surgery which may have major adverse effects? Besides the 
purely clinical assessment, the human and emotional costs involved must also 
be considered.
2. What is the ‘spontaneous’ option? What do the patient, their family members, 
the treating physician, the nursing staff and the medical team want? What is 
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the impact of pressure from fellow doctors or hospital managers, for instance 
in the event of a shortage of inpatient beds. What is the possible impact of 
pressure from the media?
3. What are the values at stake for each of the parties concerned? To answer 
this question it is necessary to draw up a personalised list of the hierarchy 
of values at stake, in the specific clinical situation, for the main parties con-
cerned, mainly the patient, but also her family members (clearly where they 
have a say) and the medical team. For example, in the case of surgery entailing 
the risk of serious adverse effects and disability, the patient might refuse the 
surgery if she feels that the degree of beneficence, as perceived by her, is not 
adequate; the patient might instead wish to retain her current physical status, 
refusing a procedure that she considers to be invasive and destructive; this 
because the patient fears that after surgery, she might not recognise herself as 
the person she was before. On her part, the doctor may feel that the surgery 
will enable the patient to survive with what the doctor considers an acceptable 
quality of life (beneficence/maleficence). In other cases, the reverse may hap-
pen: the patient and his family members may want the surgery to be performed 
Figure 2. 
Jonsen’s four box for medical decision-making.
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no matter what, even if its positive impact may be minimal or zero (patient 
autonomy vs. doctor autonomy vs. fair allocation of resources).
4. What is the moral dilemma? The matter here is not to choose the best course of 
action, but to identify clearly the moral dilemma faced by the doctor and the 
whole team, spelling it out in the most explicit and detailed way. What must be 
decided is not whether to operate on a patient who demands a treatment that 
will yield little or no benefits, but whether to prioritise the patient’s autonomy, 
and what he considers to be beneficial, or to prioritise the professional autono-
my of the doctor, expressed through his clinical judgement on a procedure that 
he considers to be maleficent (a useless operation that will cause suffering to 
the patient) and to entail an unfair allocation of resources.
5. What are the alternatives? All too often, emotionally charged situations lead to 
a polarisation of views between just two possibilities. In the example in point 
3, the only two options considered are surgery versus non-surgery. Instead, all 
options should be considered and presented to both the patient and his family 
members: chemotherapy, palliative care, home care, etc.
6. Which was the initial spontaneous choice? It is always advisable to return to 
the first spontaneous choice and assess whether the position of the main par-
ties has evolved, and whether they have moved closer or farther apart from 
each other or have otherwise changed their views. If a change of position did 
happen, it should be considered whether this could help to reduce the conflict.
7. Making the decision. The decision must be made after consultation with 
the main parties involved, first and foremost the patient, but also his family 
members (where their involvement is authorised by the patient), the medi-
cal team, etc. It is important to have an open attitude and to truly listen. The 
patient must be seen not only from a medical point of view, but as an all-round 
individual with a life story, beliefs and concerns. As J. F. Malherbe [21] said, 
the patient remains the protagonist of his illness and not just the object of 
treatment. One should not hesitate to consult a colleague to get a second opin-
ion, or even the hospital’s ethics committee. After exhausting all these steps, a 
decision must be made. The decision must be justified by taking into account 
the medical evidence for each situation, but also the ethical issues specific to 
the situation. It is essential to specify which elements justify the principles that 
were given priority in the decision-making process.
5. Issues in implementing ethical principles
In theory, the description of ethical principles seems to give a clear overview 
of medical ethics and the procedures to be followed when making treatment 
decisions.
However, in clinical practice, the application of ethical principles is increasingly 
complex and is often affected by issues that complicate the decision-making process 
and come into conflict with ethical principles. Some issues arise when different 
principles clash with each other; others are linked to patient-specific situations, 
while yet others are linked to the organisation of services.
With regard to the conflict between principles, a common opposition may arise 
between the principles of autonomy and beneficence, for example in terminal cancer 
patients. According to the principle of autonomy, the patient should be told that her 
11
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condition is now terminal, to allow her to freely choose among treatment options and 
decide what to do with the time she still has to live. However, under the principle of 
beneficence, one might argue that providing such accurate information might cause 
deep pain, and hence be harmful to the patient, affecting negatively her will to live 
and her quality of life in the time left to her. Moreover, the conflict between the two 
principles is not an abstract one; on the contrary, it is experienced by the parties to 
the decision-making process, with real consequences. The principle of autonomy can 
be interpreted in very different ways by doctors. For example, some doctors might 
resort to the legacy of medical paternalism and feel authorised to deliver all the bad 
news to the patient; other doctors could rely on the principle of autonomy to avoid 
making difficult decisions by shifting the responsibility onto the patient and/or her 
family members, placing a heavy emotional burden on the patient; still other doctors 
may not provide the full set of options to their patient to prevent her from making 
decisions that the doctor does not consider beneficial to her, resorting to a sort of 
‘palliative paternalism’ [22] and thereby arbitrarily reducing the patient’s free choice.
Conflict may also occur between the principles of beneficence and non-malef-
icence. An example is found in pain management for terminal patients, where the 
use of opioids relieves pain and meets the beneficence principle, but may shorten 
life, thereby violating the non-maleficence principle. Both principles are not 
absolute and are often combined, as in the above example, giving rise to the ‘double 
effect’ phenomenon, a term that in bioethics refers to an action that can have more 
than one result and contrasts two principles [17].
1. Other issues in the application of ethical principles arise when healthcare systems 
have to contend with limited resources. In these cases, the first ethical problem 
is patient selection for access to and discharge from care, which clashes with the 
principles of beneficence, non-maleficence and justice [23, 24]. The American 
Medical Association [25] has provided guidance on the ethical implications of 
the allocation of organs for transplant, which may be helpful in the task of deter-
mining priority of access to scarce and costly medical resources. The AMA paper 
has identified five criteria related to the patient’s Medical Needs, which should be 
considered when making resource allocation decisions: likelihood of benefit
2. the improvement in quality of life
3. the duration of the benefit to the patient
4. the urgency of the patient’s condition
5. only in some cases, the amount of resources required for successful treatment
These criteria help to maximise three primary goals of medical treatment: 
number of lives saved, number of years saved and improvement in quality of life. 
A hierarchy of objectives prioritises the goal of saving the greatest number of lives. 
[25] While the AMA document makes an important contribution to ethical deci-
sion-making, many questions about distributive justice and discrimination against 
older people remain open.
Furthermore, major social changes have affected the organisation of health 
systems and have further complicated the application of ethical principles. The 
globalisation of modern society, with its marked contradictions, inequalities and 
injustices has also inevitably affected healthcare systems. The undoubtedly success-
ful McDonaldization phenomenon, [26], characterised by efficiency, productivity, 
cost reduction, procedural standardisation and control, has also influenced the 
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organisation of healthcare services. The double pressure to cut costs and make a 
profit has impoverished the healthcare system, hitting hardest the most vulnerable 
and deprived citizens and generating major inequalities in the access to healthcare 
services: this has deeply affected the ethical principle of justice and beneficence and 
has altered the doctor-patient relationship [27].
6. Current issues
In 2020, the whole world was struck by the Covid-19 pandemic. The pandemic 
disrupted life for every person with an unexpected, novel situation and caused an 
unprecedented humanitarian emergency. Its sudden outbreak has put the health 
systems under massive strain, causing a number of ethical problems for healthcare 
staff and managers, and giving rise to real challenges to basic ethical principles.
Compounding the existing problems in applying ethical principles, the pan-
demic has brought about new complex scenarios and issues, which have not always 
been addressed appropriately and in line with ethical principles.
The first moral dilemma posed by the pandemic relates to the strain on health-
care quality caused by the surge in demand. The pandemic has spread quickly, 
catching the health structures unprepared to handle the rapid increase in workload. 
At the height of the crisis, the number of patients rose dramatically and the hospi-
tals soon ran out of beds. The number of healthcare workers (doctors and nurses) 
was also insufficient to deal with the surge in cases. Many health workers faced the 
additional workload with great dedication and sense of responsibility, aware that 
their patients’ lives also depended on their willingness to put in the extra hours. 
They prioritised the beneficence for their patients over their personal well-being. 
Many healthcare workers fell ill and many died [28]. At the peak of the pandemic, 
medical and nursing staff worked 12–14 hours a day wearing uncomfortable face 
masks, visors and coveralls. It is fair to assume that fatigue and stress at work may 
have affected the quality of care, hence the actual beneficence for patients. It can 
also be presumed that the quality of the care provided at the start of a work shift 
was higher than that provided by the same worker after 12 hours of gruelling work. 
Thus, the actual working conditions undermined both the principle of beneficence 
and the principle of justice, according to which all patients must be treated equally.
Moreover, the spike in patient numbers was so high that it produced an imbal-
ance between the healthcare needs of the population and the availability of intensive 
care resources. The situation that came about was and still is an exceptional one, 
to the extent that it has been classified as ‘disaster medicine’ [29]. With regard 
to intensive care, in addition to the criteria for access to and termination of care, 
traditionally based on the appropriateness and proportionality of care, the criteria 
of distributive justice and appropriate allocation of limited health resources had to 
be applied. The ‘first-come, first-served’ criterion for access could not be applied. 
Healthcare workers were forced to carry out an unusual triage, in which they often 
had to apply the criterion of ‘greater life expectancy’. In Italy, SIAARTI (the Italian 
Society of Anaesthesiology, Analgesia, Resuscitation and Intensive Care) issued 
‘Clinical ethics recommendations for the allocation of intensive care treatments, in 
exceptional, resource-limited circumstances’ [29]. The recommendations are solidly 
grounded in ethical principles, to relieve clinicians from the burden of making sub-
jective decisions, and establish explicit resource allocation criteria [29]. (SIAARTI). 
Robert et al. highlighted the ethical issues in patient management in intensive 
care units during the pandemic in France [30]. Despite the guidance provided, the 
dramatic pressure of the situation often forced physicians to grapple alone with 
the final decision about who should get life-saving care. While admittedly it was 
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necessary to make a selection among the patients, we must also note that a dramatic 
discrimination occurred by age group, comorbidity and patient type. Elderly 
patients, patients with comorbidities and frail patients were often denied access to 
the ICU.
The pandemic emergency also gave rise to other issues. Many patients could 
not even reach the hospital and died at home while waiting for an ambulance that 
never arrived. In those cases, the decision was not guided by any particular and 
specific recommendations, but was simply left to chance: the lottery of life decided 
for them.
For the patients’ protection, during their stay in hospital, the patient-family 
and healthcare worker-caregiver connection was severed, counter to more than 
20 years of research and care practice aimed at improving those relationships for 
the patient’s benefit [30]. Many patients were left to face death alone, without the 
comfort of family members, without any spiritual or religious care. As hospitals 
were overwhelmed, much was attempted to provide the benefit to the body but little 
was done to provide psychological and emotional care; healthcare moved back from 
caring for the whole person to focusing on the illness alone.
Yet other decisions have impacted ethical principles and good clinical practice 
in the management of chronic patients. For a long time now, the healthcare system 
has placed emphasis on prevention and early diagnosis programmes, educating the 
public about the importance of health screening and monitoring. The emergency 
has deeply disrupted this approach. Many cancer patients have been unable to 
attend their routine checks, and the same has happened to patients with heart 
conditions or diabetes. The principles of beneficence and non-maleficence have 
been severely compromised. An increase in deaths due to cardiovascular diseases 
has already been recorded, and the number of deaths secondary to cancer is also 
expected to rise [31].
7. Conclusions
The above overview confirms that the practical application of ethical principles 
in medicine is fraught with difficulties that may complicate the decision-making 
process. The current pandemic is confronting us with novel organisational, social 
and ethical challenges.
As a rule, major changes in healthcare occur at a much slower pace, giving us 
enough time to process them, adapt and make decisions. Today’s explosive crisis 
calls instead for urgent emergency measures. The assessment tools we have used so 
far have been made obsolete by the extraordinary pace of the crisis. In the health 
sector, clinical guidelines have traditionally been the gold standard for good clinical 
practice, in addition to providing some protection from medical liability. However, 
many guidelines have lost their relevance in the pandemic, which has created an 
unprecedented health situation for which no specific guidance could be prepared. 
The dramatic developments have put ethical principles under strain in various 
circumstances and cases. Moral dilemmas have severely affected the emotional 
resilience of clinical staff; in the near future we will have to deal with the moral 
distress they experienced.
Ethics, once a discipline of interest to scholars, has nowadays taken on a promi-
nent role in the social debate. However, moral questions must be addressed and ana-
lysed critically, in order to define not only what is right, but also why it is right [32].
Hopefully, we can draw some lessons from this tragedy.
The rationalisation of healthcare resources – through major budget cuts, the 
push for standardised care processes according to the McDonaldization model, 
Bioethics in Medicine and Society
14
the emphasis on hi-tech and highly specialised care – has not withstood the test 
of the pandemic. While of course it is hard to say which model would withstood 
the Covid crisis, it remains a fact that the current one failed, and this requires 
some reflection.
First, we should strengthen the human dimension of the physician-patient 
relationship. The focus on performance and profit has reduced the time available for 
listening to patients and their family members; as medical professionals, we have 
contributed to the achievement of the productivity targets set by the health authori-
ties, but we have not always respected the ethical principles of an authentic doctor-
patient relationship based on caring for the individual as opposed to simply treating 
a medical condition. Health professionals should take the brave step of fostering the 
relationship with their patients and prioritising quality over quantity, eschewing 
the industrial assembly line model: people are not machines and do not function like 
machines.
Social systems as a whole should revisit their resource allocation models. For a 
long time now, policy makers from all sides have made major cuts to health care; the 
pandemic has shown that ‘sick countries’ with difficulties in the delivery of health-
care are also countries with persistent economic problems. The share of public 
spending allocated to healthcare should be fairer, instead of treating the health 
service as the poor relation.
During the pandemic, we helped the patients with the greatest chance of 
survival, but we were unable to help the frailest ones. We went back to the model 
of Sparta, the ancient Greek city where frail male infants were tossed off a cliff, to 
train the others to become strong and valiant warriors. However, the Spartan model 
was not the one that prevailed in ancient Greece, nor the one that produced the 
greatest protagonists of classical culture. Healthcare systems, with the contribution 
of medical ethics, should develop care models that protect the frailest and shelter 
them from ‘competition’ for survival in which they would be doomed from the start.
We should also send the message that medical ethics is not just a matter for the 
individual health professional but is the responsibility of the whole community. 
The pandemic is teaching us that the responsible behaviour of each of us plays a 
key role in preventing the spread of the infection. The principles of medical ethics, 
beneficence and non-maleficence should be better known, understood and applied 
not only by health workers but by all persons.
Last but not least, the expectations placed on doctors today are very high, if not 
excessive, as concerns both clinical skills and patient relations. Although ethical 
issues are now on the front line, there is still very little training in biomedical ethics 
for health professionals. The development of science and technology require that 
physicians be knowledgeable of ethical issues pertinent to end-of-life care [33, 34]. 
It is crucial to invest more in this of training, to ensure that the new generations 
of doctors and other health professionals, within their respective roles, are better 
equipped to face the new challenges for  medical ethics.
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